Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy.

Taheri A, Dinarvand R, Nouri FS, Khorramizadeh MR, Borougeni AT, Mansoori P, Atyabi F.

Int J Nanomedicine. 2011;6:1863-74. doi: 10.2147/IJN.S23949. Epub 2011 Sep 8.

2.

The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.

Taheri A, Dinarvand R, Ahadi F, Khorramizadeh MR, Atyabi F.

Int J Pharm. 2012 Jul 15;431(1-2):183-9. doi: 10.1016/j.ijpharm.2012.04.033. Epub 2012 Apr 15.

PMID:
22531853
3.

Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells.

Taheri A, Dinarvand R, Atyabi F, Ghahremani MH, Ostad SN.

Eur J Pharm Sci. 2012 Sep 29;47(2):331-40. doi: 10.1016/j.ejps.2012.06.016. Epub 2012 Jul 6.

PMID:
22771547
4.

Targeted delivery of methotrexate to tumor cells using biotin functionalized methotrexate-human serum albumin conjugated nanoparticles.

Taheri A, Dinarvand R, Atyabi F, Nouri F, Ahadi F, Ghahremani MH, Ostad SN, Borougeni AT, Mansoori P.

J Biomed Nanotechnol. 2011 Dec;7(6):743-53.

PMID:
22416572
6.

In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.

Wosikowski K, Biedermann E, Rattel B, Breiter N, Jank P, Löser R, Jansen G, Peters GJ.

Clin Cancer Res. 2003 May;9(5):1917-26.

7.

Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.

Riebeseel K, Biedermann E, Löser R, Breiter N, Hanselmann R, Mülhaupt R, Unger C, Kratz F.

Bioconjug Chem. 2002 Jul-Aug;13(4):773-85.

PMID:
12121133
8.

Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.

Li Q, Liu C, Zhao X, Zu Y, Wang Y, Zhang B, Zhao D, Zhao Q, Su L, Gao Y, Sun B.

Int J Nanomedicine. 2011;6:397-405. doi: 10.2147/IJN.S16144. Epub 2011 Feb 20.

9.

Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.

Hartung G, Stehle G, Sinn H, Wunder A, Schrenk HH, Heeger S, Kränzle M, Edler L, Frei E, Fiebig HH, Heene DL, Maier-Borst W, Queisser W.

Clin Cancer Res. 1999 Apr;5(4):753-9.

10.

Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles.

Corem-Salkmon E, Ram Z, Daniels D, Perlstein B, Last D, Salomon S, Tamar G, Shneor R, Guez D, Margel S, Mardor Y.

Int J Nanomedicine. 2011;6:1595-602. doi: 10.2147/IJN.S23025. Epub 2011 Aug 3.

11.

In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.

Endo N, Kato Y, Takeda Y, Saito M, Umemoto N, Kishida K, Hara T.

Cancer Res. 1987 Feb 15;47(4):1076-80.

12.

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis.

Wunder A, Müller-Ladner U, Stelzer EH, Funk J, Neumann E, Stehle G, Pap T, Sinn H, Gay S, Fiehn C.

J Immunol. 2003 May 1;170(9):4793-801.

13.

Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease.

Wolff D, Frei E, Hofmeister N, Steiner B, Kleine HD, Junghanss C, Sievert K, Terpe H, Schrenk HH, Freund M, Hartung G.

Transplantation. 2006 Aug 27;82(4):527-33.

PMID:
16926597
14.

Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.

Taheri A, Dinarvand R, Atyabi F, Ahadi F, Nouri FS, Ghahremani MH, Ostad SN, Borougeni AT, Mansoori P.

Int J Mol Sci. 2011;12(7):4591-608. doi: 10.3390/ijms12074591. Epub 2011 Jul 15.

15.

Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX.

Fiehn C, Müller-Ladner U, Gay S, Krienke S, Freudenberg-Konrad S, Funk J, Ho AD, Sinn H, Wunder A.

Rheumatology (Oxford). 2004 Sep;43(9):1097-105. Epub 2004 Jun 15.

16.

Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.

Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC.

Int J Pharm. 2011 Jan 17;403(1-2):285-91. doi: 10.1016/j.ijpharm.2010.10.041. Epub 2010 Oct 28.

PMID:
21035530
18.

Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.

Bae S, Ma K, Kim TH, Lee ES, Oh KT, Park ES, Lee KC, Youn YS.

Biomaterials. 2012 Feb;33(5):1536-46. doi: 10.1016/j.biomaterials.2011.10.050. Epub 2011 Nov 25.

PMID:
22118776
19.

Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo.

Burger AM, Hartung G, Stehle G, Sinn H, Fiebig HH.

Int J Cancer. 2001 Jun 1;92(5):718-24.

20.

A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles.

Wu P, He X, Wang K, Tan W, He C, Zheng M.

J Biomed Nanotechnol. 2009 Oct;5(5):557-64.

PMID:
20201432
Items per page

Supplemental Content

Write to the Help Desk